Overview of Alcohol Use Disorder.
Kranzler HR.
Am J Psychiatry. 2023 Aug 1;180(8):565-572. doi: 10.1176/appi.ajp.20230488.
Toxicity of energy drinks.
Wolk BJ, Ganetsky M, Babu KM.
Curr Opin Pediatr. 2012 Apr;24(2):243-51. doi: 10.1097/MOP.0b013e3283506827.
A neural substrate of comorbid depressive symptoms in alcohol use.
Chen Z, Yang S, Leng L, Ding J, Yuan Z, Zhuang K, Can D, Zou T, Wang Y, Li H, Yuan TF, Zhang J.
Mol Psychiatry. 2025 Oct;30(10):4677-4689. doi: 10.1038/s41380-025-03061-6. Epub 2025 May 27.
Alcohol and melatonin.
Kurhaluk N.
Chronobiol Int. 2021 Jun;38(6):785-800. doi: 10.1080/07420528.2021.1899198. Epub 2021 Mar 24.
GDNF and alcohol use disorder.
Barak S, Ahmadiantehrani S, Logrip ML, Ron D.
Addict Biol. 2019 May;24(3):335-343. doi: 10.1111/adb.12628. Epub 2018 May 4.
Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal.
Mayo-Smith MF.
JAMA. 1997 Jul 9;278(2):144-51. doi: 10.1001/jama.278.2.144.
Alcohol and disinhibition.
Källmén H, Gustafson R.
Eur Addict Res. 1998 Dec;4(4):150-62. doi: 10.1159/000018948.
Alcoholism and reproduction.
Heine MW.
Prog Biochem Pharmacol. 1981;18:75-82.
Pharmacotherapy in alcoholism.
Miller NS.
J Addict Dis. 1995;14(1):23-46. doi: 10.1300/J069v14n01_04.
Recent Efforts to Dissect the Genetic Basis of Alcohol Use and Abuse.
Sanchez-Roige S, Palmer AA, Clarke TK.
Biol Psychiatry. 2020 Apr 1;87(7):609-618. doi: 10.1016/j.biopsych.2019.09.011. Epub 2019 Sep 25.
